摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(4-fluorophenyl)pyrazine-2-carboxylic acid | 515813-06-6

中文名称
——
中文别名
——
英文名称
6-(4-fluorophenyl)pyrazine-2-carboxylic acid
英文别名
6-(4Fluorophenyl)pyrazine-2-carboxylic acid
6-(4-fluorophenyl)pyrazine-2-carboxylic acid化学式
CAS
515813-06-6
化学式
C11H7FN2O2
mdl
——
分子量
218.187
InChiKey
FXHFCFGKDCMINT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.1
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • 5-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
    申请人:——
    公开号:US20040242868A1
    公开(公告)日:2004-12-02
    Compounds of formula (I): 1 or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    化学式为(I)的化合物1或其药学上可接受的盐或溶剂,以及它们作为药物的用途,特别是作为p38激酶抑制剂。
  • [EN] 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER<br/>[FR] DÉRIVÉS DE 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHÉNYL)-PYRIDIN-3-YL)MÉTHANONE ET COMPOSÉS SIMILAIRES SERVANT D'INHIBITEURS DE CYP11A1 POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
    申请人:ORION CORP
    公开号:WO2022117920A1
    公开(公告)日:2022-06-09
    The present invention relates to compounds of formula (I) wherein A is a 3-10 membered carbocyclyl or a 4-12 membered heterocyclyl containing 1-4 heteroatoms selected from O, N or S; B is any of the following groups (1) (2) or (3 ); C is any of the following groups (1') (2') (3") or (4') G1is CH2, NH or O; G2and G3are, independently, is CH or N: Z is -C(O)-, -SO2-, -C1-3alkyl- or -CH2-C(O)-; L is a bond, -C1-7alkyl- or -C1-7alkenyl-; The compounds of formula (I) are cytochrome P450 monooxygenase 11A1 (CYP11A1) inhibitors. The compounds are useful as medicaments in the treatment of steroid receptor, for example androgen receptor or estrogen receptor, dependent diseases and conditions, such as cancer including prostate cancer and estrogen cancer.
    本发明涉及式(I)化合物,其中A是3-10个成员的碳环或4-12个成员的杂环,其中包含1-4个从O、N或S中选择的杂原子;B是以下任意一组(1)、(2)或(3);C是以下任意一组(1')、(2')、(3")或(4');G1是CH2、NH或O;G2和G3分别是CH或N;Z是-C(O)-、-SO2-、-C1-3烷基-或-CH2-C(O)-;L是键、-C1-7烷基-或-C1-7烯基-;式(I)化合物是细胞色素P450单加氧酶11A1(CYP11A1)抑制剂。这些化合物在治疗类固醇受体,例如雄激素受体或雌激素受体依赖性疾病和病况,如包括前列腺癌和雌激素癌在内的癌症中,作为药物是有用的。
  • 5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS
    申请人:GLAXO GROUP LIMITED
    公开号:EP1435934A1
    公开(公告)日:2004-07-14
  • US7432289B2
    申请人:——
    公开号:US7432289B2
    公开(公告)日:2008-10-07
  • [EN] 5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS<br/>[FR] DERIVES DE 5'-ACYLAMINO-1,1'-BIPHENYL-4-CARBOXAMIDE ET LEUR UTILISATION COMME INHIBITEURS DE LA KINASE P 38
    申请人:GLAXO GROUP LTD
    公开号:WO2003032971A1
    公开(公告)日:2003-04-24
    Compounds of formula (I): wherein R3 is the group -NH-CO-R6; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
查看更多